Nelson Vergel
Founder, ExcelMale.com
Two randomized controlled trials examined the effect of testosterone on postmenopausal women with HSDD. One trial randomized 272 women ages 40 to 70 years to a 300-mcg transdermal testosterone patch (TTP; 142 women) or placebo (130 women).1 At 6 months, women using the TTP reported more sexually satisfying episodes (1.69 vs 0.59 episodes in 4 weeks;P=.0089) and a minimal increase in sexual desire scores (12.2 vs 4.56 on a 100-point sexual desire scale; P=.0007) compared with women using placebo.
A second trial randomized 814 postmenopausal women (mean age 54.2 years) to placebo (277 women), a 150-mcg TTP (267 women), or a 300-mcg TTP (270 women).2 At 24 weeks, women taking 300 mcg (but not 150 mcg) of testosterone reported a greater number of satisfying sexual episodes than women taking placebo (2.1 vs 0.7; P<.0001). The 300-mcg TTP caused more unwanted hair growth than placebo (19.9% vs 10.5%; no P value given). The study didn't continue long enough to assess cardiovascular risks.
Recently approved: Bremelanotide (Vyleesi) for Female Sexual Disorder
Source:
Which treatments help women with reduced libido?
J Fam Pract. 2013 February;62(2):102-103.
Keia Hobbs, MD
Pharmaceutical and Energy-Based Management of Sexual Problems in Women
BACKGROUND TO A NEW ERA To discuss “a new era” in the management of sexual dysfunction implies progress from a previous norm, so that discussion must begin with an understanding of the historical foundations and associated assumptions undergirding that progress. This is particularly true of...
www.excelmale.com
Therapeutic options for treatment of Female Sexual Dysfunction
Medical Treatment of Female Sexual Dysfunction (2022) Rossella E. Nappi, MD, PhD, Lara Tiranini, MD, Ellis Martini, MD, David Bosoni, MD, Alessandra Righi, MD, Laura Cucinella, MD INTRODUCTION A sexual problem associated with personal distress in women qualifies as a female sexual dysfunction...
www.excelmale.com
Most recent advances in pharmacotherapy for female sexual dysfunctions
Pharmacotherapy for female sexual dysfunctions (FSDs): what is on the market and where is this field heading? (2022) Rossella E. Nappi, Lara Tiranini, Laura Cucinella, Ellis Martini, David Bosoni, Alessandra Righi, Chiara Cassani, and Barbara Gardella ABSTRACT Introduction: Female sexual...
www.excelmale.com
Last edited: